{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:50:15Z","timestamp":1711641015732},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00467-019-04440-2","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T09:04:46Z","timestamp":1576227886000},"page":"979-980","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nephrotic syndrome in a patient with cystinuria: Answers"],"prefix":"10.1007","volume":"35","author":[{"given":"Ozlem Yuksel","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilgun","family":"Cakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"4440_CR1","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1097\/01.ASN.0000029586.17680.E5","volume":"13","author":"L Dello Strologo","year":"2002","unstructured":"Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M, Bisceglia L, Zelante L, Jimenez-Vidal M, Font M, Zorzano A, Rousaud F, Nunes V, Gasparini P, Palac\u00edn M, Rizzoni G (2002) Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13:2547\u20132553","journal-title":"J Am Soc Nephrol"},{"key":"4440_CR2","first-page":"105","volume":"57","author":"J Sany","year":"1990","unstructured":"Sany J, Combe B, Verdie-Petibon D, Tagemouati A, Daures JP (1990) Long-term tolerability of tiopronin (acadione) in the treatment of rheumatoid arthritis. Apropos of 140 personal cases. Rev Rhum Mal Osteoartic 57:105\u2013111","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"4440_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00431-010-1315-3","volume":"170","author":"V Tasic","year":"2011","unstructured":"Tasic V, Lozanovski VJ (2011) Nephrotic syndrome occurring during tiopronin treatment for cystinuria. Eur J Pediatr 170:247\u2013249. https:\/\/doi.org\/10.1007\/s00431-010-1315-3","journal-title":"Eur J Pediatr"},{"key":"4440_CR4","first-page":"663","volume":"84","author":"RJ Reveillaud","year":"1978","unstructured":"Reveillaud RJ, Blanc G, Daudon M (1978) Nephrotic syndrome and skin disorders appearing during alpha-mercapto-propionyl-glycine treatment of 2 cases of cystinic lithiasis. J Urol Nephrol 84:663\u2013667","journal-title":"J Urol Nephrol"},{"key":"4440_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3109\/0886022X.2014.926754","volume":"36","author":"Z Zheng","year":"2014","unstructured":"Zheng Z, Xue Y, Jia J, Wei L, Shang W, Lin S (2014) Tiopronin-induced membranous nephropathy: a case report. Ren Fail 36:1455\u20131460. https:\/\/doi.org\/10.3109\/0886022X.2014.926754","journal-title":"Ren Fail"},{"key":"4440_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0022-5347(17)56420-4","volume":"122","author":"G Rizzoni","year":"1979","unstructured":"Rizzoni G, Pavanello L, Dussini N, Chiandetti L, Zacchello G (1979) Nephrotic syndrome during treatment with alpha-mercaptopropionylglycine. J Urol 122:381\u2013382","journal-title":"J Urol"},{"key":"4440_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/art.1780280526","volume":"28","author":"G Salvarani","year":"1985","unstructured":"Salvarani G, Macchioni P, Rossi F, Iori I, Filippi G (1985) Nephrotic syndrome induced by tiopronin: associated with the HLA-DR3 antigen. Arthritis Rheum 28:595\u2013596","journal-title":"Arthritis Rheum"},{"key":"4440_CR8","first-page":"9","volume":"4","author":"GF Ferraccioli","year":"1986","unstructured":"Ferraccioli GF, Peri F, Nervetti A, Mercadanti M, Cavalieri F, Dall\u2019Aglio PP, Savi M, Ferrari C (1986) Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics. Clin Exp Rheumatol 4:9\u201315","journal-title":"Clin Exp Rheumatol"},{"key":"4440_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/atm.2019.07.42","volume":"7","author":"H Zhong","year":"2019","unstructured":"Zhong H, Wang L, Gu Z, Cui M, Liu X, Pang X (2019) Minimal change disease induced by tiopronin: a rare case report and a review of the literature. Ann Transl Med 7:398. https:\/\/doi.org\/10.21037\/atm.2019.07.42","journal-title":"Ann Transl Med"},{"key":"4440_CR10","first-page":"87","volume":"25","author":"P Stratta","year":"1978","unstructured":"Stratta P, Coratelli P, Camussi G, Passavanti G, Segoloni GP, Coppo R, Amerio A, Vercellone A (1978) Sindrome nefrosica durante trattamento con 2-mercaptopropionilglicina. Minerva Nefrol 25:87\u201392","journal-title":"Minerva Nefrol"},{"key":"4440_CR11","first-page":"235","volume":"41","author":"U Ambanelli","year":"1982","unstructured":"Ambanelli U, Manganelli P, Ferraccioli GF (1982) Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients. Z Rheumatol 41:235\u2013239","journal-title":"Z Rheumatol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04440-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:30:04Z","timestamp":1607733004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4440"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04440-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}